pipobroman has been researched along with dipyridamole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chistolini, A; Falcione, E; Ferrari, A; Francesconi, M; Mandelli, F; Mazzucconi, MG; Tirindelli, MC | 1 |
2 other study(ies) available for pipobroman and dipyridamole
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Pipobroman therapy of essential thrombocythemia.
Topics: Adult; Aged; Dipyridamole; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pipobroman; Thrombocythemia, Essential; Time Factors | 1986 |